The signing of the Neu3CA memorandum of understanding with representatives of TU/e, Kempenhaeghe and Ghent University (Hospital).
From left to right: drs Marlène Chatrou (chair of Kempenhaeghe board), prof dr Ignance Lemahieu (research director Ghent University), prof dr Eric Mortier (CEO UZ Gent), Carmen van Vilsteren, MSc (director Strategic Area Health, TU/e), dr Evelien Carrette (clinical program director Neu3CA), prof dr Paul Boon (head of Neurology department UZ Gent, chair R&D Kempenhaeghe), dr ir René Besseling (technical program director Neu3CA), prof dr ir Bart Smolders (dean department Electrical Engineering, TU/e), prof. dr. Piet Hoebeke (dean Faculty of Medicine Ghent University), prof dr ir Jan Bergmans (head of Signal Processing Systems group, TU/e), prof dr Bert Aldenkamp (head behavioral research and vice-chair R&D Kempenhaeghe).
Neu3CA is a multidisciplinary and multi-institute research progam. To facilitate the cooperation between TU/e, Kempenhaeghe and Ghent University & University Hospital, a Memorandum of Understand (MOU) was signed in Ghent on October 24th. This event was picked up by several media: